Mark P. Guerin
2022
In 2022, Mark P. Guerin earned a total compensation of $844.7K as Chief Operating Officer and Chief Financial Officer at Onconova Therapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Bonus | $144,383 |
|---|---|
| Option Awards | $155,813 |
| Salary | $452,000 |
| Stock Awards | $59,619 |
| Other | $32,884 |
| Total | $844,699 |
Guerin received $452K in salary, accounting for 54% of the total pay in 2022.
Guerin also received $144.4K in bonus, $155.8K in option awards, $59.6K in stock awards and $32.9K in other compensation.
Rankings
In 2022, Mark P. Guerin's compensation ranked 3,387th out of 5,760 executives tracked by ExecPay. In other words, Guerin earned more than 41.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,387 out of 5,760 | 41st |
Division Manufacturing | 1,918 out of 3,136 | 39th |
Major group Chemicals And Allied Products | 915 out of 1,422 | 36th |
Industry group Drugs | 856 out of 1,323 | 35th |
Industry Pharmaceutical Preparations | 623 out of 969 | 36th |
Source: SEC filing on June 7, 2023.
Guerin's colleagues
We found two more compensation records of executives who worked with Mark P. Guerin at Onconova Therapeutics in 2022.